Pulmonary arterial hypertension pah is a severe condition characterised by elevated pulmonary artery pressure leading to right heart failure and death 1, 2. It is a complication of highdose chemotherapy given before a bone marrow transplant bmt and is marked by weight gain due to fluid retention, increased liver size, and raised levels of bilirubin in the blood. It leads to high blood pressure in the lung arteries pulmonary hypertension. This suggests a possible genetic contribution in some circumstances.
Hepatic veno occlusive disease vod, also known as sinusoidal obstruction syndrome sos, can develop in a subset of patients, primarily after myeloablative hematopoietic stem cell transplantation, but it also may occur after reducedintensity conditioning. Hepatic veno occlusive disease is a condition that blocks occludes small veins in the liver, disrupting blood flow in this organ. Center for lung research under the file title pvod patients. Hepatic sinusoidal obstruction syndrome sos, previously termed hepatic veno occlusive disease vod, is one of the most feared complications of allogeneic and autologous hematopoietic cell transplantation hct. Progressively worsening dyspnea and signs of heart failure such as fatigue and blood pressure changes are manifestations of pvod. Pulmonary venoocclusive disease pvod is a very rare disorder of the small veins in the lungs. Pulmonary venoocclusive disease pvod is a rare form of pulmonary hypertension which occurs in 0.
Pulmonary venoocclusive disease pvod is characterized by the blockage occlusion of the blood vessels that carry oxygenrich oxygenated blood from the lungs to the heart the pulmonary veins. Get a printable copy pdf file of the complete article 266k, or click on a page image below to browse page by page. The imaging findings are a result of this fibrotic occlusion. Pulmonary veno occlusive disease and scleroderma associated pulmonary hypertension. Hepatic venoocclusive disease sinusoidal obstruction.
Pulmonary venoocclusive disease american journal of. The term pulmonaryvaso occlusive disease has been suggested by others, asadditional pathologic evidence has demonstrated arterial as well asvenous changes. Pulmonary veno occlusive disease pvod is an uncommon subtype of pah with a particularly poor prognosis. Guest editorial pulmonary venoocclusive disease and pulmonary hypertension in dogs. Pulmonary venoocclusive disease pvod, a variant of pulmonary arterial hypertension, is a rare complication that can occur after hematopoietic stem cell transplantation hsct and chemotherapy. The mortality remains high, related, at least partly, to the limited treatment options. The incidence, prevalence, and etiology of pvod in children are not well defined. Multimedia encyclopedia pulmonary venoocclusive disease. Clinical roundtable monograph clinical advance in hematology. Other pulmonary hypertension veno occlusive disease, portopulmonary hypertension pulmonary vasculitis and capillaritis pulmonary veno occlusive disease generally carries a poor prognosis some report a 72% mortality at one year from diagnosis 1. Links to pubmed are also available for selected references.
Pulmonary veno occlusive disease generally carries a poor prognosis some report a 72% mortality at one year from diagnosis 1. Pulmonary veno occlusive disease pvod is a clinicopathologic syndrome that accounts for a small number of cases of pulmonary hypertension. Pulmonary veno occlusive disease pvod is one of the less commonly encountered causes of pulmonary hypertension. The high blood pressure occurs in the pulmonary arteries.
Hepatic venoocclusive disease radiology reference article. Nov 01, 2008 in severe cases, multiple organ failure or severe bacterial infections may occur. Hepatic veno occlusive disease vod or sinusoidal obstructive syndrome sos is a disorder characterised by obstruction of small intrahepatic venules and damage to the surrounding centrilobular hepatocytes and sinusoids. Hepatic veno occlusive disease or veno occlusive disease with immunodeficiency vodi is a condition in which some of the small veins in the liver are obstructed. Pulmonary venoocclusive disease in childhood chest. The disease may be commoner than it is currently held to be. Pulmonary disease certification examination blueprint purpose of the exam the exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment. Pulmonary veno occlusive disease pvod is considered to be a subtype of pulmonary arterial hypertension pah and is characterized by obstruction of small pulmonary veins that leads to increased pressure in the pulmonary circulation. Some reports suggest that pvod accounts for 520% of cases classified as idiopathic pulmonary arterial hypertension pah. The incidence and prevalence of pvod is not well characterized.
Severe sosvod resulting in modmof, is characterized by pulmonary andor renal dysfunction andor. Pulmonary veno occlusive disease pvod is a rare form of pulmonary hypertension caused by progressive blockage of the small veins in the lungs. Hepatic sinusoidal obstruction syndromevenoocclusive disease. Oct 16, 2018 pulmonary veno occlusive disease pvod is one of the less commonly encountered causes of pulmonary hypertension. If there is pulmonary hypertension with roentgenographic signs of pulmonary edema and of congestion in the absence. Pulmonary veno occlusive disease definition pulmonary veno occlusive disease pvod is a very rare disease. It accounts for a significant fraction of transplantrelated mortality and, in its severe form, is almost always fatal. In contrast to the insights into pathophysiology and management that have characterized the diagnosis and treatment of idiopathic pulmonary arterial hypertension ipah. This factsheet has been produced to help you understand more about vod. Pulmonary veno occlusive disease pvod is a rare and fatal cause of pulmonary hypertension ph that is difficult to diagnose and treat. Venoocclusive disease vod, also known as sinusoidal obstruction syndrome, is a potentially lifethreatening complication of hsct the conditioning regimens given before hsct result in the production of toxic metabolites by the hepatocytes in the liver these metabolites trigger the activation, damage and inflammation of the endothelial. Pulmonary veno occlusive disease pvod is a rare form of pulmonary hypertension ph characterised by preferential remodelling of the pulmonary venules. Hepatic venoocclusive disease violetta kivovich md, phd 2. Pulmonary vod pvod as a clinical entity is even more poorly understood than hepatic vodsos.
We strongly recommend that you talk with a trusted. A normal pulmonary capillary wedge pressure was recorded in the presence of severe pulmonary arterial hypertension and roentgenographic evidence of pulmonary venous congestion. Pulmonary venoocclusive disease pvod is a rare form of pulmonary hypertension ph characterised by preferential remodelling of the pulmonary venules. Rare, usually children and adolescents, especially females also after cancer chemotherapy causes pulmonary hypertension secondary to widespread thromboemboli of large and medium size branches of pulmonary vein. Pulmonary venoocclusive disease and scleroderma associated pulmonary hypertension. Pulmonary venoocclusive diseasecausessymptomstreatment. Pulmonary veno occlusive disease pvod is a rare cause of pulmonary hypertension with high morbidity and mortality. Pulmonary venoocclusive disease genetics home reference. The term pulmonary vaso occlusive disease has been suggested by others, as additional patho. Pulmonary venoocclusive disease is progressive and life threatening. Abstract pulmonary venoocclusive disease pvod is a rare form of pulmonary hypertension ph characterised by preferential remodelling of the pulmonary venules.
Know the causes, symptoms, treatment, prognosis, pathophysiology and epidemiology of. Pulmonary veno occlusive disease pvod is a very rare disorder of the small veins in the lungs. Pulmonary venoocclusive disease radiology reference. Hepatic venoocclusive disease or veno occlusive disease with immunodeficiency vodi is a condition in which some of the small veins in the liver are obstructed. Pulmonary veno occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Its signs and symptoms appear after the first few months of life.
Hepatic veno occlusive disease after bone marrow transplantation. In 2006, roscioli et al 1 described mutations in the promyelocytic leukemia protein pml nuclear body protein sp110 in six children from five families of lebanese ethnicity, who met the clinical criteria for. Pulmonary venoocclusive disease genetic and rare diseases. Though the aetiology of pulmonary veno occlusive disease remains obscure, earlier recognition and treatment with anticoagulants may improve the prognosis. Tuder 3 pulmonary hypertension ph in both humans and animals remains an enigmatic problem. Pulmonary venoocclusive disease pvod is currently classified as a subgroup of pulmonary arterial hypertension pah and accounts for 510% of cases initially considered to be idiopathic pah. Hepatic venoocclusive disease genetic and rare diseases. Apr 09, 2018 pulmonary venoocclusive disease is a very rare condition in which pulmonary hypertension takes place. Pulmonary arterial hypertension pah is a rare disease sometimes associated with collagen vascular diseases, usually limited scleroderma crest syndrome. Erj000262016 march 2016 with 633 reads how we measure reads. Mar 01, 2020 if you have problems viewing pdf files, download the latest version of adobe reader for language access assistance, contact the ncats public information officer genetic and rare diseases information center gard po box 8126, gaithersburg, md 208988126 tollfree.
Pulmonary venoocclusive disease pvod is a clinicopathologic syndrome that accounts for a small number of cases of pulmonary hypertension. Pulmonary venoocclusive disease pvod is a rare lung disease, diagnosed in 5% to 10% of patients with pulmonary hypertension ph. The disease is progressive and fatal, with median survival of about 2 years from the time of diagnosis to death. Hepatic veno occlusive disease vod, also called sinusoidal. Pulmonary venoocclusive disease pvod is a rare form of pulmonary arterial hypertension pah, 1 characterized by extensive and diffuse intimal fibrotic narrowing or occlusion of the small. The occlusion is caused by a buildup of abnormal fibrous tissue in the small veins in the lungs, which narrows the vessels and impairs blood flow. Impressive clinical signs and symptoms often obscure the true underlying capillary disorder, thus severely compromising timely and appropriately directed therapy. If you have problems viewing pdf files, download the latest version of adobe reader for language access assistance, contact the ncats public information officer genetic and rare diseases information center gard po box 8126, gaithersburg, md 208988126 tollfree. There are rare families that have been described where multiple family members have been affected by the disease. Pulmonary veno occlusive disease pvod is a rare condition with poor prognosis, and lung transplantation is recommended as the only curative therapy. The condition can be caused by drinking bush tea containing pyrrolizidine alkaloids, and in other ways.
Imaging description pulmonary venoocclusive disease pvod is considered a cause of pulmonary hypertension that preferentially affects the postcapillary pulmonary vasculature. Venoocclusive diseasesinusoidal obstruction syndrome. Ph in all species can occur idiopathically or can be associated with a wide variety of disease conditions. Pulmonary veno occlusive disease pulmonary capillary hemangiomatosis pvodpch is a rare condition that represents a subgroup of patients with pulmonary hypertension. Pdf sinusoidal obstruction syndromevenoocclusive disease. Pulmonary veno occlusive disease pvod andor pulmonary capillary hemangiomatosis pch 1. Severe vodsos, typically characterized by multiorgan failure, has been associated with a mortality rate greater than 80%. Pdf the authors sought to evaluate the diagnostic accuracy of highresolution computed tomography hrct in the detection of pulmonary venoocclusive.
Pulmonary veno occlusive disease pvod is a very rare disease. Pvod has been described as idiopathic or complicating other conditions, including connective tissue diseases, hiv infection, bone marrow transplantation. Although blood and marrow transplants can save patients lives, they can also result in numerous complications, including infections, renal failure, and liver complications, such as venoocclusive disease vod. Risk factors for development of and progression of hepatic veno. Pvod has been described as idiopathic or complicating other conditions, including connective tissue diseases, hiv infection, bone marrow transplantation, sarcoidosis and pulmonary langerhans cell. Alternative names pulmonary vaso occlusive disease causes in most cases, the cause of pvod is unknown. Sinusoidal obstruction syndrome hepatic venoocclusive disease. The pathologic hallmark of pvod is the extensive and diffuse occlusion of pulmonary veins by fibrous tissue. Recent conjoint european respiratory societyeuropean society of cardiology guidelines suggest that nonmatched perfusion defects on ventilationperfusion v. Get a printable copy pdf file of the complete article 2. Pvod is usually idiopathic, however it has also been associated with chemotherapy exposure and rheumatic diseases. Diagnosis and severity criteria for sinusoidal obstruction syndrome. Pulmonary venoocclusive disease pulmonary venoocclusive. It is important to note that vasodilators commonly used to treat patients with primary pulmonary hypertension.
The present study reports a case of biopsyproven pulmonary veno occlusive disease as a cause of severe pulmonary hypertension in a patient suffering from a chronic. Questions and answers about veno occlusive disease vod. Sinusoidal obstruction syndrome or venoocclusive disease sosvod. The blockage leads to high blood pressures in the arteries of the lungs, which, in turn, leads to heart failure. Symptoms include hyperbilirubinemia, painful hepatomegaly and ascites. The lower images show pulmonary artery and right ventricular enlargement and signs of elevated rightsided pressures, findings typical of pulmonary veno occlusive disease. Pulmonary venoocclusive disease pvod is classified as a subgroup of pah and accounts for 510% of histological forms of cases initially considered to be idiopathic pah. The aim of this study was to describe our experience at one institution with pulmonary veno occlusive disease pvod during the past 10 years, with particular reference to new findings and long. Hepatic venoocclusive disease vod is a common complication of the chemotherapeutic.
Pulmonary veno occlusive disease pvod is characterized by the blockage occlusion of the blood vessels that carry oxygenrich oxygenated blood from the lungs to the heart the pulmonary veins. Pulmonary veno occlusive disease pvod, a rare form of pulmonary arterial hypertension pah, requires histological proof for definitive diagnosis. Veno occlusive disease is not another illness, but a complication that affects the liver. Pulmonary venoocclusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Pulmonary venoocclusive disease in myeloproliferative disorder e. Pulmonary venoocclusive disease is a rare and usually fatal condition in which there is gradual obliteration of the pulmonary veins and venules. Pulmonary venoocclusive disease in myeloproliferative disorder article pdf available in european respiratory journal 331. Pulmonary venoocclusive disease pubmed central pmc. This leads to obstructed blood flow within the small pulmonary veins thereby causing high blood pressure in the pulmonary arteries. Sinusoidal obstruction syndromevenoocclusive disease. Hepatic veno occlusive disease is a lifethreatening condition in which toxic substances either chemotherapeutic drugs or pyrrolizidine alkaloids found in various herbal remedies cause severe damage to the endothelial cells of sinusoidal vessels in the liver, resulting in massive fibrosis and blood flow obstruction.
Pdf sinusoidal obstruction syndrome or venoocclusive disease. Persistent pulmonary hypertension of the newborn pphn pah is a rare and debilitating disease characterized by abnormal proliferation and contraction of pulmonary artery smooth muscle cells. Manifestations and management of venoocclusive disease. Vod can occur in as high as 70% of patients and is the most common hepatic complication in the immediate posttransplant period.
Pulmonary vasculopathy is a wellrecognized feature of radiation injury, but it is seldom of major clinical significance. Oct 16, 2018 pulmonary veno occlusive disease after chemotherapy. The role of pulmonary arterial hypertension targeted therapy in pvod remains controversial, and longterm effects of targeted therapy have been rarely reported. Hepatic veno occlusive disease vod, also known as sinusoidal obstruction syndrome sos, is a condition arising from occlusion of hepatic venules. Pulmonary veno occlusive disease in an adult following bone marrow transplantation. First described in 1934 by dr julius hora of the university of munich, 1 pvod is characterized by widespread occlusion of the pulmonary venules by. Veno occlusive disease of the liver after marrow transplantation. Management of hepatic veno occlusive disease vod background. Aubrypulmonary veno occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease rheumatol int, 27 12 2007, pp.
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno occlusive disease. Prophylactic, preemptive, and curative treatment for. Hepatic venoocclusive disease after hematopoietic stem cell. Pulmonary venoocclusive disease in myeloproliferative. Full text full text is available as a scanned copy of the original print version. Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome veno occlusive disease in adult patients. Immunohistochemical identification of the material within occluded central venules. Pulmonary venoocclusive disease european respiratory. Pdf pulmonary venoocclusive disease in myeloproliferative. In general, pvod progresses rapidly such that early recognition and treatment of this entity is critical.
Pulmonary veno occlusive disease pvod is a rare and highly lethal disorder of the pulmonary vasculature. Jr five cases of an undescribed form of pulmonary interstitial fibrosis caused by obstruction of the pulmonary veins. Pulmonary venoocclusive disease pvod is a very rare disease. Without a lung biopsy the conical diagnosis of this disease is difficult. Questions and answers about veno occlusive disease vod ebmt. Hepatic veno occlusive disease with immunodeficiency also called vodi is a hereditary disorder of the liver and immune system. In developed countries, hepatic veno occlusive disease is mainly associated with the conditioning regimen for hematopoietic stem cell transplantation, with 10 to 60% of transplant patients depending on the conditioning regimen protocol used developing hepatic vod. A 17yearold boy with pulmonary veno occlusive disease underwent swanganz catheterization. In the current ph classification, pvod and pulmonary capillary haemangiomatosis pch are considered to be a common entity and represent varied expressions of the same disease.
366 1531 196 154 350 547 733 882 548 405 878 412 440 1069 1619 631 683 1429 1122 1542 397 256 1258 474 207 98 1142 1365 268 703 17 134 930 201 130 386 23 1130 1190 286 1396 1159 1101 1087 910 1279 1434 1184